A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

Arinobu Tojo, Kensuke Usuki, Akio Urabe, Yasuhiro Maeda, Yukio Kobayashi, Itsuro Jinnai, Kazuma Ohyashiki, Miki Nishimura, Tatsuya Kawaguchi, Hideo Tanaka, Koichi Miyamura, Yasushi Miyazaki, Timothy Hughes, Susan Branford, Shinichiro Okamoto, Jun Ishikawa, Masaya Okada, Noriko Usui, Hiromi Tanii, Taro AmagasakiHiroko Natori, Tomoki Naoe

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL'. Together they form a unique fingerprint.

Medicine & Life Sciences